| Identification | Back Directory | [Name]
3-Benzofuranaceticacid,2,3-dihydro-6-hydroxy-,Methylester | [CAS]
805250-17-3 | [Synonyms]
CS-1044
SR03298A
SR-03298A;SR 03298A;SR03298A
Methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)
Methyl 6-Hydroxy-2,3-dihydrobenzofuran-3-ylacetate
METHYL 2-(6-HYDROXY-2,3-DIHYDROBENZOFURAN-3-YL)ACETATE
Methyl (6-hydroxy-2,3-dihydro-1-benzofuran-3-yl)acetate
-Benzofuranaceticacid,2,3-dihydro-6-hydroxy-,Methylester
3-Benzofuranaceticacid,2,3-dihydro-6-hydroxy-,Methylester
methyl 2-(6-hydroxy-2,3-dihydro-1-benzofuran-3-yl)acetate
Methyl 2-(5-hydroxy-2,3-dihydro-1-benzofuran-3-yl)acetate
(6-Hydroxy-2,3-dihydrobenzofuran-3-yl)acetic acid methyl ester | [Molecular Formula]
C11H12O4 | [MDL Number]
MFCD19703879 | [MOL File]
805250-17-3.mol | [Molecular Weight]
208.211 |
| Chemical Properties | Back Directory | [Boiling point ]
326.5±42.0℃ (760 Torr) | [density ]
1.257±0.06 g/cm3 (20 ºC 760 Torr) | [Fp ]
126.9±21.4℃ | [storage temp. ]
Sealed in dry,Room Temperature | [pka]
9.77±0.40(Predicted) |
| Hazard Information | Back Directory | [Uses]
(6-Hydroxy-2,3-dihydrobenzofuran-3-yl)acetic Acid Methyl Ester was used in the synthetic preparation of TAK-875 (T004915), a novel oral medication that has been developed to improve the secretion of i
nsulin in a glucose-dependent manner, which has the potential to improve the control of blood sugar levels without the risk of hypoglycemia. |
|
|